NHC Submits Comments on FDA’s Draft Guidance for Voluntary Incorporation of Patient Preference Information (PDF) December 5, 2024 The Honorable Robert M. Califf, MD Commissioner U.S. Food and Drug Administration […]
Letters + Comments
NHC Comments on Patient Priorities for the Lame Duck
NHC Comments on Patient Priorities for the Lame Duck NHC Comments on Patient Priorities for the Lame Duck (PDF) November 22, 2024 The Honorable Chuck Schumer […]
NHC Comments on CMS 2026 Notice of Benefit and Payment Parameters
NHC Comments on CMS 2026 Notice of Benefit and Payment Parameters (PDF) November 12, 2024 Chiquita Brooks-LaSure Administrator Centers for Medicare & Medicaid Services Department of Health and Human Services […]
NHC Comments on Landmark FDA Guidance for Diversity in Clinical Trials
NHC Comments on Landmark FDA Guidance for Diversity in Clinical Trials (PDF) September 26, 2024 The Honorable Robert M. Califf, MD Commissioner U.S. Food and Drug Administration 5630 Fishers Lane […]
NHC Comments on Centers for Medicare & Medicaid Services (CMS) in response to the proposed rule Medicare and Medicaid Programs: Calendar Year 2025 Payment Policies under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies
NHC Comments on Centers for Medicare & Medicaid Services (CMS) in response to the proposed rule Medicare and Medicaid Programs: Calendar Year 2025 Payment Policies under the Physician Fee Schedule […]
NHC Comments on Centers for Medicare & Medicaid Services (CMS) in response to the CY 2025 OPPS proposed rule
NHC Comments on Centers for Medicare & Medicaid Services (CMS) in response to the CY 2025 OPPS proposed rule (PDF) September 9, 2024 Chiquita Brooks-LaSure Administrator Centers for Medicare & […]
NHC Comments on Negotiation Data Elements and Drug Price Negotiation Process for Initial Price Applicability Year 2027 under Sections 11001 and 11002 of the IRA ICR Forms
NHC Comments on Negotiation Data Elements and Drug Price Negotiation Process for Initial Price Applicability Year 2027 under Sections 11001 and 11002 of the Inflation Reduction Act (IRA) Information Collection […]
NHC Comments on Framework for Discussion on Reforming the NIH
NHC Comments on Framework for Discussion on Reforming the NIH (PDF) August 16, 2024 The Honorable Cathy McMorris Rodgers Chair Committee on Energy and Commerce U.S. House of Representatives Washington, […]
NHC Comments on Request for Information (RFI) on the future of 21st Century Cures 2.0 legislation
NHC Comments on Request for Information (RFI) on the future of 21st Century Cures 2.0 legislation (PDF) August 2, 2024 The Honorable Diana DeGette […]
NHC Comments on National Institutes of Health (NIH) Office of Science Policy (OSP): Request for Information on Draft NIH Intramural Research Program Policy: Promoting Equity Through Access Planning
NHC Comments on National Institutes of Health (NIH) Office of Science Policy (OSP): Request for Information on Draft NIH Intramural Research Program Policy: Promoting Equity Through Access Planning (PDF) July […]